Prospective quality of life impact of keratinocyte carcinomas: Observations from the Veterans Affairs Topical Tretinoin Chemoprevention Trial - 24/04/13
Veterans Affairs Topical Tretinoin Chemoprevention (VATTC) Trial Group
Members of the Veterans Affairs Topical Tretinoin Chemoprevention Trial Group are listed in the Appendix. |
|
Supported by the VA Cooperative Studies Program (CSP#402), Office of Research and Development, Department of Veterans Affairs. Additional support was received from the American Cancer Society. The study medication was donated by the OrthoNeutrogena division of Ortho-McNeil Pharmaceutical. Dr Weinstock is supported by grants R01CA106592, R01CA106807, R25CA087972, and R01AR49342 from the National Institutes of Health. |
|
Conflicts of interest: None declared. |
Vol 63 - N° 6
P. 1107-1109 - décembre 2010 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?